Biography

Keith Pfeil has served as our President and Chief Executive Officer since July 2025. Keith serves on our Board of Directors and is a member of the Nominating and Corporate Governance Committee. Previously, he served as Chief Operating Officer and Chief Financial Officer, where he led the Company’s operations, finance, tax, pricing and contracts, internal audit, quality, information technology, investor relations, strategy and business development functions. In addition, he oversaw the Company’s biologics business unit—Bone Bank Allografts. Keith helped lead the Company’s acquisition of NuVasive and served on the Executive Steering Committee for the integration of the Globus Medical and NuVasive businesses.

Keith joined the Company as Chief Financial Officer in August 2019 after more than 15 years at CSS Industries, Inc., a publicly traded consumer products company. At CSS, he served as the Executive Vice President and Chief Financial Officer.  Prior to that role, Keith served in various financial roles of increasing responsibility with focus areas including audit, business development, controllership, financial planning and analysis, investor relations and treasury. Prior to CSS Industries, he worked in the transaction advisory practice of Ernst & Young LLP, and prior to that, he worked in the assurance practices of KPMG LLP and Arthur Andersen LLP.

Keith received a B.S. in accounting from Elizabethtown College and an Executive M.B.A. from Saint Joseph’s University.